314 related articles for article (PubMed ID: 25369368)
1. Epigenetic alterations in acute myeloid leukemias.
Mehdipour P; Santoro F; Minucci S
FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation as a pathogenic event and as a therapeutic target in AML.
Schoofs T; Müller-Tidow C
Cancer Treat Rev; 2011; 37 Suppl 1():S13-8. PubMed ID: 21612874
[TBL] [Abstract][Full Text] [Related]
3. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
4. Molecularly targeted therapy in acute myeloid leukemia.
Gill H; Leung AY; Kwong YL
Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
[TBL] [Abstract][Full Text] [Related]
5. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia: therapeutic impact of epigenetic drugs.
Altucci L; Clarke N; Nebbioso A; Scognamiglio A; Gronemeyer H
Int J Biochem Cell Biol; 2005 Sep; 37(9):1752-62. PubMed ID: 15964234
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
Wouters BJ; Delwel R
Blood; 2016 Jan; 127(1):42-52. PubMed ID: 26660432
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.
Xu J; Hang X; Wu B; Chen C; Liu Y
Adv Exp Med Biol; 2019; 1143():173-189. PubMed ID: 31338820
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic targeting and personalized approaches for AML.
Roboz GJ
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
[TBL] [Abstract][Full Text] [Related]
10. New strategies for relapsed acute myeloid leukemia: fertile ground for translational research.
Dinner SN; Giles FJ; Altman JK
Curr Opin Hematol; 2014 Mar; 21(2):79-86. PubMed ID: 24419335
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms in AML - a target for therapy.
Oki Y; Issa JP
Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
Newcombe AA; Gibson BES; Keeshan K
Exp Hematol; 2018 Jul; 63():1-11. PubMed ID: 29608923
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia.
Ojeda-Uribe M; Schneider A; Luquet I; Berceanu A; Cornillet-Lefebvre P; Jeandidier E; Lioure B; Ades L; Mauvieux L; Himberlin C
Eur J Haematol; 2012 Sep; 89(3):267-72. PubMed ID: 22591288
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
Eriksson A; Lennartsson A; Lehmann S
Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
[TBL] [Abstract][Full Text] [Related]
15. [Acute myeloid leukemia].
Döhner K; Paschka P; Döhner H
Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulators and their impact on therapy in acute myeloid leukemia.
Pastore F; Levine RL
Haematologica; 2016 Mar; 101(3):269-78. PubMed ID: 26928248
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
18. Reasons for optimism in the therapy of acute leukemia.
Rowe JM
Best Pract Res Clin Haematol; 2015; 28(2-3):69-72. PubMed ID: 26590761
[TBL] [Abstract][Full Text] [Related]
19. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells.
Lai YS; Chen JY; Tsai HJ; Chen TY; Hung WC
Blood Cancer J; 2015 May; 5(5):e313. PubMed ID: 25978433
[TBL] [Abstract][Full Text] [Related]
20. New treatment for acute myelogenous leukemia.
DiNardo CD; Cortes JE
Expert Opin Pharmacother; 2015 Jan; 16(1):95-106. PubMed ID: 25480777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]